| MicroRNA biomarkers in whole blood for detection of pancreatic cancer NA Schultz, C Dehlendorff, BV Jensen, JK Bjerregaard, KR Nielsen, ... Jama 311 (4), 392-404, 2014 | 468 | 2014 |
| Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil P Pfeiffer, D Nielsen, J Bjerregaard, C Qvortrup, M Yilmaz, B Jensen Annals of oncology 19 (6), 1141-1145, 2008 | 120 | 2008 |
| Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis M Graversen, S Detlefsen, JK Bjerregaard, CW Fristrup, P Pfeiffer, ... Therapeutic advances in medical oncology 10, 1758835918777036, 2018 | 72 | 2018 |
| Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer F Brännström, JK Bjerregaard, A Winbladh, M Nilbert, A Revhaug, ... Acta oncologica 54 (4), 447-453, 2015 | 68 | 2015 |
| Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) M Graversen, S Detlefsen, JK Bjerregaard, P Pfeiffer, MB Mortensen Clinical & experimental metastasis 34, 309-314, 2017 | 67 | 2017 |
| Diagnostic and prognostic impact of circulating YKL-40, IL-6, and CA 19.9 in patients with pancreatic cancer NA Schultz, IJ Christensen, J Werner, N Giese, BV Jensen, O Larsen, ... PloS one 8 (6), e67059, 2013 | 50 | 2013 |
| The effect of aromatase inhibitors on bone metabolism L Folkestad, NH Bjarnason, JK Bjerregaard, K Brixen Basic & clinical pharmacology & toxicology 104 (1), 3-10, 2009 | 47 | 2009 |
| Automatic treatment planning facilitates fast generation of high-quality treatment plans for esophageal cancer CR Hansen, M Nielsen, AS Bertelsen, I Hazell, E Holtved, R Zukauskaite, ... Acta Oncologica 56 (11), 1495-1500, 2017 | 42 | 2017 |
| Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients JK Bjerregaard, MB Mortensen, KR Schønnemann, P Pfeiffer European journal of cancer 49 (1), 98-105, 2013 | 42 | 2013 |
| Prognostic impact of Charlson’s Age‐Comorbidity Index and other risk factors in patients with pancreatic cancer K Bagni, IM Chen, AZ Johansen, C Dehlendorff, BV Jensen, CP Hansen, ... European Journal of Cancer Care 29 (3), e13219, 2020 | 37 | 2020 |
| Maintenance therapy with cetuximab every second week in the first-line treatment of metastatic colorectal cancer: the NORDIC-7.5 study by the nordic colorectal cancer … P Pfeiffer, H Sorbye, C Qvortrup, M Karlberg, C Kersten, K Vistisen, ... Clinical colorectal cancer 14 (3), 170-176, 2015 | 36 | 2015 |
| Age favoured overall survival in a large population-based Danish patient cohort treated with anti-PD1 immune checkpoint inhibitor for metastatic melanoma L Bastholt, H Schmidt, JK Bjerregaard, J Herrstedt, IM Svane European Journal of Cancer 119, 122-131, 2019 | 35 | 2019 |
| Phase II study of biweekly cetuximab in combination with irinotecan as second-line treatment in patients with platinum-resistant gastro-oesophageal cancer KR Schønnemann, M Yilmaz, JK Bjerregaard, KM Nielsen, P Pfeiffer European Journal of Cancer 48 (4), 510-517, 2012 | 30 | 2012 |
| Trends in cancer of the liver, gall bladder, bile duct, and pancreas in elderly in Denmark, 1980–2012 JK Bjerregaard, MB Mortensen, P Pfeiffer, ... Acta Oncologica 55 (sup1), 40-45, 2016 | 28 | 2016 |
| Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum KR Schoennemann, JK Bjerregaard, TP Hansen, K De Stricker, ... Gastric Cancer 14, 219-225, 2011 | 27 | 2011 |
| Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy JK Bjerregaard, MB Mortensen, HA Jensen, M Nielsen, P Pfeiffer International Journal of Radiation Oncology* Biology* Physics 83 (3), 909-915, 2012 | 22 | 2012 |
| Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer JK Bjerregaard, MB Mortensen, HA Jensen, C Fristrup, B Svolgaard, ... Radiotherapy and Oncology 92 (2), 226-230, 2009 | 21 | 2009 |
| Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer LS Rasmussen, MK Yilmaz, UG Falkmer, LØ Poulsen, M Bøgsted, ... European Journal of Cancer 144, 72-80, 2021 | 20 | 2021 |
| Prognostic value of combined detection of serum IL6, YKL-40, and C-reactive protein in patients with unresectable pancreatic cancer IM Chen, AZ Johansen, C Dehlendorff, BV Jensen, SE Bojesen, P Pfeiffer, ... Cancer Epidemiology, Biomarkers & Prevention 29 (1), 176-184, 2020 | 17 | 2020 |
| Simplification of cetuximab (Cet) administration: double dose every second week as a 60 minute infusion P Pfeiffer, JK Bjerregaard, C Qvortrup, BV Jensen, M Yilmaz, D Nielsen Journal of Clinical Oncology 25 (18_suppl), 4133-4133, 2007 | 15 | 2007 |
Inna ChenMDVerified email at regionh.dk
